Concomitant administration of interleukin-2 during therapeutic vaccinations against cancer: the good, the bad, or the evil?

Mads Hald Andersen; Julie Gehl; Sine Reker; Poul Geertsen; Jürgen C Becker; Per thor Stratem

doi:10.1200/JCO.2004.00.9837

Concomitant administration of interleukin-2 during therapeutic vaccinations against cancer: the good, the bad, or the evil?

Mads Hald Andersen, Julie Gehl, Sine Reker, Poul Geertsen, Jürgen C Becker, Per thor Stratem

Afdeling for Kræftbehandling HGH

6 Citationer (Scopus)

Originalsprog	Engelsk
Tidsskrift	Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Vol/bind	23
Udgave nummer	22
Sider (fra-til)	5265-7; author reply 5267-8
ISSN	0732-183X
DOI	https://doi.org/10.1200/JCO.2004.00.9837
Status	Udgivet - 1 aug. 2005

Adgang til dokumentet

10.1200/JCO.2004.00.9837

Citationsformater

Andersen, M. H., Gehl, J., Reker, S., Geertsen, P., Becker, J. C., & thor Stratem, P. (2005). Concomitant administration of interleukin-2 during therapeutic vaccinations against cancer: the good, the bad, or the evil? Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 23(22), 5265-7; author reply 5267-8. https://doi.org/10.1200/JCO.2004.00.9837

Concomitant administration of interleukin-2 during therapeutic vaccinations against cancer: the good, the bad, or the evil? / Andersen, Mads Hald; Gehl, Julie; Reker, Sine et al.
I: Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Bind 23, Nr. 22, 01.08.2005, s. 5265-7; author reply 5267-8.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Andersen, MH, Gehl, J, Reker, S, Geertsen, P, Becker, JC & thor Stratem, P 2005, 'Concomitant administration of interleukin-2 during therapeutic vaccinations against cancer: the good, the bad, or the evil?', Journal of clinical oncology : official journal of the American Society of Clinical Oncology, bind 23, nr. 22, s. 5265-7; author reply 5267-8. https://doi.org/10.1200/JCO.2004.00.9837

@article{6f732cca116f42ce8c4cc667277bde24,

title = "Concomitant administration of interleukin-2 during therapeutic vaccinations against cancer: the good, the bad, or the evil?",

keywords = "CD8-Positive T-Lymphocytes, Cancer Vaccines, Drug Administration Schedule, Humans, Interleukin-2, Melanoma, Skin Neoplasms",

author = "Andersen, {Mads Hald} and Julie Gehl and Sine Reker and Poul Geertsen and Becker, {J{\"u}rgen C} and {thor Stratem}, Per",

year = "2005",

month = aug,

day = "1",

doi = "10.1200/JCO.2004.00.9837",

language = "English",

volume = "23",

pages = "5265--7; author reply 5267--8",

journal = "Journal of clinical oncology : official journal of the American Society of Clinical Oncology",

issn = "0732-183X",

publisher = "Lippincott Williams and Wilkins",

number = "22",

}

TY - JOUR

T1 - Concomitant administration of interleukin-2 during therapeutic vaccinations against cancer

T2 - the good, the bad, or the evil?

AU - Andersen, Mads Hald

AU - Gehl, Julie

AU - Reker, Sine

AU - Geertsen, Poul

AU - Becker, Jürgen C

AU - thor Stratem, Per

PY - 2005/8/1

Y1 - 2005/8/1

KW - CD8-Positive T-Lymphocytes

KW - Cancer Vaccines

KW - Drug Administration Schedule

KW - Humans

KW - Interleukin-2

KW - Melanoma

KW - Skin Neoplasms

U2 - 10.1200/JCO.2004.00.9837

DO - 10.1200/JCO.2004.00.9837

M3 - Journal article

C2 - 16051975

SN - 0732-183X

VL - 23

SP - 5265-7; author reply 5267-8

JO - Journal of clinical oncology : official journal of the American Society of Clinical Oncology

JF - Journal of clinical oncology : official journal of the American Society of Clinical Oncology

IS - 22

ER -